Piers Franco Ordonez

Speaking from the Oval Office, President Trump announced a deal with Eli Lilly and Novo Nordisk for their GLP-1 drugs that treat diabetes and obesity.

The deal includes coverage by Medicare and Medicaid, which could mean new customers for the companies, and the administration says about 10 percent of Medicare enrollees will be eligible.

The drugs will also be available to purchase online in a direct-to-consumer marketplace that the Trump administration plans to launch, called TrumpRx.

Franco Ordonez, NPR News, the White House.